L-Citrulline: Clinical Dose Ranges and What the Research Describes

What L-citrulline is

L-citrulline is a non-essential amino acid naturally found in watermelon and some other foods. It is a precursor in the urea cycle and, when ingested, is converted to L-arginine in the kidneys. L-arginine is a substrate for nitric oxide synthase, the enzyme that produces nitric oxide (NO) — a signalling molecule involved in vasodilation. Supplementing citrulline is a more effective way to raise plasma arginine than supplementing arginine directly, because arginine undergoes substantial first-pass metabolism in the gut and liver.

L-citrulline is sold both as free amino acid (L-citrulline) and as citrulline malate — a compound of citrulline and malic acid. The distinction matters for dose calculation; see below.

The clinical dose range

Acute dosing (single pre-workout dose) is the typical protocol in trials, taken 60 minutes before exercise. Unlike beta-alanine, citrulline does not require a loading period.

What trials have measured

Research on L-citrulline covers two distinct areas: cardiovascular endpoints (blood pressure and arterial stiffness) and exercise performance.

For blood pressure, trials in individuals with mild hypertension and in healthy adults find that supplementation with 3,000–6,000 mg/day over several weeks is associated with modest reductions in systolic blood pressure. The effect is generally larger in those with elevated baseline blood pressure. A 2018 meta-analysis of 8 randomised trials found a statistically significant reduction in resting systolic blood pressure of approximately 4–5 mmHg. This is considered a modest effect in clinical terms but is directionally consistent across trials.

For exercise performance, the most-cited trials use 6,000–8,000 mg of L-citrulline or citrulline malate before resistance or endurance exercise. Outcomes measured include total repetitions completed, perceived exertion, and time to exhaustion. Results are mixed — some trials find meaningful improvements in training volume and reduced soreness; others find smaller or non-significant effects. The evidence base is sufficient to justify inclusion in pre-workout formulas but not to claim consistent, large performance improvements.

Underdosing in commercial products

L-citrulline is one of the most egregiously underdosed ingredients in commercial pre-workouts. The effective trial dose is 6,000–8,000 mg; the Proco Scanner homepage example shows a pre-workout product with only 2,000 mg — a pattern that is typical, not exceptional.

• 2,000–3,000 mg servings: Extremely common; well below the 6,000 mg minimum trial dose.
• Citrulline malate labelled as equivalent to citrulline: A product with 4,000 mg of citrulline malate 2:1 delivers approximately 2,800 mg of citrulline — less than half the trial dose.
• Blend concealment: Citrulline inside a "pump blend" or "nitric oxide matrix" with undisclosed individual quantities.

Documented safety considerations

L-citrulline is generally well tolerated in trials at the studied doses. Gastrointestinal discomfort at very high doses is occasionally reported. The blood pressure-lowering effect, while modest, is a consideration for individuals already on antihypertensive medication or those with low baseline blood pressure. L-citrulline should be used with caution alongside phosphodiesterase inhibitors (such as sildenafil) given the shared nitric oxide pathway.

How Proco Scanner evaluates it

When the Scanner reads L-citrulline or citrulline malate, it calculates the citrulline content — adjusting for the malate ratio where relevant — and checks it against the 6,000–8,000 mg trial dose range. Products below 6,000 mg of citrulline equivalent are flagged as underdosed relative to the evidence base.

Proco Scanner reads any supplement label and surfaces what the published research describes for each ingredient — dose, evidence quality, and known considerations. Coming to iOS. Join the waitlist for early access.